{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:40:20Z","timestamp":1790138420423,"version":"4.0.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008921","name":"Saskatchewan Agriculture Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008921","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ontario Cattlemen Association"},{"name":"Funding Consortium of Alberta"},{"name":"Cattle Industry Development Council, BC, Canada"},{"DOI":"10.13039\/501100000106","name":"Saskatchewan Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000106","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.vaccine.2014.11.055","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T14:22:30Z","timestamp":1418134950000},"page":"493-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Bovine adenovirus-3 as a vaccine delivery vehicle"],"prefix":"10.1016","volume":"33","author":[{"given":"Lisanework E.","family":"Ayalew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Makadiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh K.","family":"Tikoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2014.11.055_bib0005","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1099\/vir.0.19497-0","article-title":"Genetic content and evolution of adenoviruses","volume":"84","author":"Davison","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0010","series-title":"The viruses and their replication fields virology","first-page":"2355","article-title":"Adenoviridae","author":"Berk","year":"2007"},{"issue":"3","key":"10.1016\/j.vaccine.2014.11.055_bib0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-84-20714","article-title":"Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture","volume":"84","author":"Rowe","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.055_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3181\/00379727-85-20825","article-title":"Recovery of new agent from patients with acute respiratory illness","volume":"85","author":"Hilleman","year":"1954","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.124.3212.119","article-title":"Adenoviruses: group name proposed for new respiratory tract viruses","volume":"124","author":"Enders","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0030","series-title":"Fundamental virology","first-page":"1053","article-title":"The viruses and their replication","author":"Shenk","year":"2001"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0035","series-title":"Virus taxonomy. 8th Report of the international committee on taxonomy of viruses","first-page":"213","article-title":"Family adenoviridae","author":"Benk\u00f6","year":"2005"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0040","series-title":"Virus taxonomy: IXth report of the international committee on taxonomy of viruses","first-page":"125","article-title":"Family adenoviridae","author":"Harrach","year":"2011"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0045","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0042-6822(92)90082-Z","article-title":"The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2","volume":"186","author":"Chroboczek","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0050","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1099\/vir.0.007773-0","article-title":"Functional organization of the major late transcriptional unit of canine adenovirus type 2","volume":"90","author":"Szelechowski","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0055","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1099\/vir.0.80757-0","article-title":"Complete genome sequence of simian adenovirus 1: an old world monkey adenovirus with two fiber genes","volume":"86","author":"Kov\u00e1cs","year":"2005","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.055_bib0060","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1128\/JVI.72.2.1394-1402.1998","article-title":"Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3","volume":"72","author":"Reddy","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1099\/0022-1317-82-3-525","article-title":"The complete nucleotide sequence of porcine adenovirus sero-type 5","volume":"82","author":"Nagy","year":"2001","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.055_bib0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/viro.1998.9418","article-title":"Nucleotide sequence and transcription map of porcine adenovirus type 3","volume":"251","author":"Reddy","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0075","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","article-title":"Update on adenovirus and its vectors","volume":"81","author":"Russell","year":"2000","journal-title":"J Gen Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2014.11.055_bib0080","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1128\/JVI.77.24.13407-13411.2003","article-title":"Detailed analysis of the CD8+ T-cell response following adenovirus vaccination","volume":"77","author":"Yang","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.11.055_bib0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1586\/14760584.6.3.347","article-title":"T-cell immunity generated by recombinant adenovirus vaccines","volume":"6","author":"Yang","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.055_bib0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/infdis\/161.1.27","article-title":"A recombinant human adenovirus vaccine against rabies","volume":"161","author":"Prevec","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0095","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1128\/JVI.70.6.3770-3780.1996","article-title":"Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus","volume":"70","author":"Torres","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0100","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(01)00458-3","article-title":"Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD","volume":"20","author":"Gogev","year":"2002","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2014.11.055_bib0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vetimm.2012.10.003","article-title":"Time-dependent biodistribution and transgene expression of a recombinant human adenovirus serotype 5-luciferase vector as a surrogate for rAd5-FMDV vaccines in cattle","volume":"151","author":"Montiel","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.055_bib0110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1637\/8773-033109-Reg.1","article-title":"Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5","volume":"54","author":"Toro","year":"2010","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0115","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization","volume":"80","author":"Gao","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0120","first-page":"467","article-title":"Canine adenovirus based rabies vaccines","volume":"131","author":"Tordo","year":"2008","journal-title":"Dev Biol"},{"issue":"27","key":"10.1016\/j.vaccine.2014.11.055_bib0125","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/S0264-410X(01)00084-6","article-title":"Vaccination of pigs with a recombinant porcine adenovirus expressing the gD gene from pseudorabies virus","volume":"19","author":"Hammond","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1099\/0022-1317-82-1-183","article-title":"Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene","volume":"82","author":"Tuboly","year":"2001","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2014.11.055_bib0135","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1099\/0022-1317-80-5-1263","article-title":"Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1","volume":"80","author":"Zakhartchouk","year":"1999","journal-title":"J Gen Virol"},{"issue":"26","key":"10.1016\/j.vaccine.2014.11.055_bib0140","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.vaccine.2014.03.073","article-title":"Mucosal immunization of calves with recombinant bovine adenovirus-3 co-expressing truncated form of bovine herpesvirus-1 gD and bovine IL-6","volume":"32","author":"Kumar","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2014.11.055_bib0145","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/CVI.00187-13","article-title":"Oral inoculation of chickens with a candidate fowl adenovirus 9 vector","volume":"20","author":"Deng","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-1119(87)90251-4","article-title":"Phylogenetic relationships between adenoviruses as inferred from nucleotide sequences of inverted terminal repeats","volume":"55","author":"Shinagawa","year":"1987","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0155","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1099\/vir.0.19418-0","article-title":"Identification of cis-acting sequences required for selective packaging of bovine adenovirus type 3 DNA","volume":"84","author":"Xing","year":"2003","journal-title":"J Gen Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2014.11.055_bib0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virusres.2007.06.015","article-title":"Bovine adenovirus-3 E1A coding region contain cis-acting DNA packaging motifs","volume":"130","author":"Xing","year":"2007","journal-title":"Virus Res"},{"issue":"12","key":"10.1016\/j.vaccine.2014.11.055_bib0165","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1099\/vir.0.82108-0","article-title":"E1A promoter of bovine adenovirus type 3","volume":"87","author":"Xing","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/viro.1999.9826","article-title":"Transcription map and expression of bovine herpesvirus-1 glycoprotein D in early region 4 of bovine adenovirus-3","volume":"261","author":"Baxi","year":"1999","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.055_bib0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/viro.1998.9510","article-title":"Characterization of early region 1 and pIX of bovine adenovirus-3","volume":"253","author":"Reddy","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/viro.1999.9626","article-title":"Transcription mapping and characterization of 284R and 121R proteins produced from early region 3 of bovine adenovirus type 3","volume":"256","author":"Idamakanti","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0185","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1099\/0022-1317-80-7-1735","article-title":"Transcription units of E1a, E1b and pIX regions of bovine adenovirus type 3","volume":"80","author":"Zheng","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2004.02.024","article-title":"Role of bovine adenovirus-3 33K protein in viral replication","volume":"323","author":"Kulshreshtha","year":"2004","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.055_bib0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.virol.2008.08.015","article-title":"Interaction of bovine adenovirus-3 33K protein with other viral proteins","volume":"381","author":"Kulshreshtha","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0200","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1099\/vir.0.065763-0","article-title":"Conserved regions of bovine adenovirus-3 pVIII contain functional domains involved in nuclear localization and packaging in mature infectious virion","volume":"95","author":"Ayalew","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0205","series-title":"Functional characterization of 100K protein of bovine adenovirus type 3","author":"Makadiya","year":"2013"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virol.2012.05.021","article-title":"Mapping of nuclear import signal and importin\u03b13 binding regions of 52K protein of bovine adenovirus-3","volume":"432","author":"Paterson","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0215","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1099\/0022-1317-75-8-2069","article-title":"The fibre of bovine adenovirus type 3 is very long but bent","volume":"75","author":"Ruigrok","year":"1994","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.055_bib0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virusres.2003.09.009","article-title":"Altered tropism of recombinant bovine adenovirus type-3 expressing chimeric fiber","volume":"99","author":"Wu","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1099\/0022-1317-76-1-93","article-title":"Development of a bovine adenovirus type 3-based expression vector","volume":"76","author":"Mittal","year":"1995","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0230","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/viro.1998.9351","article-title":"Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD","volume":"250","author":"Zakhartchouk","year":"1998","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.055_bib0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0166-0934(98)00145-1","article-title":"Generation of infectious genome of bovine adenovirus type 3 by homologous recombination in bacteria","volume":"77","author":"van Olphen","year":"1999","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0240","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/JVI.70.7.4805-4810.1996","article-title":"Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli","volume":"70","author":"Chartier","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0245","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1089\/10430349950016636","article-title":"Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells","volume":"10","author":"Rasmussen","year":"1999","journal-title":"Hum Gene Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2014.11.055_bib0250","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/jgm.1505","article-title":"Efficient replication and generation of recombinant bovine adenovirus-3 in nonbovine cotton rat lung cells expressing I-SceI endonuclease","volume":"12","author":"Du","year":"2010","journal-title":"J Gene Med"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.055_bib0255","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/viro.2001.1104","article-title":"Bovine adenovirus type 3 E1B (small) protein is essential for growth in bovine fibroblast cells","volume":"288","author":"Zhou","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0260","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1128\/JVI.73.11.9137-9144.1999","article-title":"Replication-defective bovine adenovirus type 3 as an expression vector","volume":"73","author":"Reddy","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0265","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/viro.2002.1389","article-title":"Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines","volume":"295","author":"van Olphen","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0270","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1128\/JVI.76.12.5882-5892.2002","article-title":"Development and characterization of bovine X human hybid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted","volume":"76","author":"Van Olphen","year":"2002","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2014.11.055_bib0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-1702(00)00209-4","article-title":"Optimization of bovine coronavirus hemagglutinin-esterase glycoprotein expression in E3 deleted bovine adenovirus-3","volume":"70","author":"Reddy","year":"2000","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0280","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virusres.2005.02.008","article-title":"Evaluation of promoters for foreign gene expression in E3 region of bovine adenovirus type 3","volume":"110","author":"Zhang","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0285","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/viro.2000.0661","article-title":"Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats","volume":"278","author":"Baxi","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.055_bib0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.2001.1176","article-title":"Mutational analysis of early region 4 of bovine adenovirus type 3","volume":"290","author":"Baxi","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0264-410X(93)90336-V","article-title":"Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV","volume":"11","author":"Van Drunen Little-van den Hurk","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0300","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biologicals.2012.07.003","article-title":"Immunology of BVDV vaccines","volume":"41","author":"Ridpath","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0305","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1099\/0022-1317-70-4-993","article-title":"Monoclonal antibodies to bovine coronavirus glycoproteins E2 and E3: demonstration of in vivo virus-neutralizing activity","volume":"70","author":"Deregt","year":"1989","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.055_bib0310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/viro.1995.1553","article-title":"Pathogenesis and immunogenicity of bovine adenovirus type 3 in cotton rats (Sigmodon hispidus)","volume":"213","author":"Mittal","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00497787","article-title":"Sero-prevalences of selected cattle diseases in the Kafue flats of Zambia","volume":"15","author":"Ghirotti","year":"1991","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0320","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2460\/ajvr.1979.40.04.580","article-title":"Neutralizing antibodies to bovine adenovirus serotype 3 in healthy cattle and cattle with respiratory tract disease","volume":"40","author":"Lehmkuhl","year":"1979","journal-title":"Am J Vet Res"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2014.11.055_bib0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0165-2427(00)00217-8","article-title":"The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle","volume":"76","author":"Reddy","year":"2000","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0330","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11250-011-0046-4","article-title":"Serological evaluation of relationship between viral pathogens (BHV-1, BVDV, BRSV, PI-3V, and Adeno3) and dairy calf pneumonia by indirect ELISA","volume":"44","author":"Roshtkhari","year":"2012","journal-title":"Trop Anim Health Prod"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.055_bib0335","first-page":"153","article-title":"Experimental inoculation of heifers with bovine adenovirus type 3","volume":"63","author":"Mittal","year":"1999","journal-title":"Can J Vet Res"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2014.11.055_bib0340","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0264-410X(01)00483-2","article-title":"Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24","volume":"20","author":"Moraes","year":"2002","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2014.11.055_bib0345","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1128\/JVI.79.10.6516-6522.2005","article-title":"Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates","volume":"79","author":"Santra","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0350","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-basede immunization","volume":"80","author":"Gao","year":"2006","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2014.11.055_bib0355","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.vaccine.2006.09.047","article-title":"Protective avian influenza in-ovo vaccination with non-replicating human adenovirus vector","volume":"25","author":"Toro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0360","article-title":"Recombinant bovine adenovirus -3 co-expressing bovine respiratory syncytial virus glycoprotein G and truncated glycoprotein gD of bovine herpesvirus-1 induce immune responses in cotton rats","author":"Robert","year":"2014","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0365","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/eji.1830231215","article-title":"Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo","volume":"23","author":"Ramsay","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0370","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.8160012","article-title":"The role of interleukin-6 in mucosal IgA antibody responses in vivo","volume":"264","author":"Ramsay","year":"1994","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2014.11.055_bib0375","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2567.2000.00116.x","article-title":"Recombinant adenovirus vectors expressing interleukin-5 and -6 specifically enhance mucosal immunoglobulin A responses in the lung","volume":"101","author":"Braciak","year":"2000","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2014.11.055_bib0380","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/JVI.06244-11","article-title":"Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection","volume":"86","author":"Lietz","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0385","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1742-4690-8-75","article-title":"Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes","volume":"8","author":"Bayer","year":"2011","journal-title":"Retrovirology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0390","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/JVI.77.2.1621-1625.2003","article-title":"Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease","volume":"77","author":"Chinsangaram","year":"2003","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2014.11.055_bib0395","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/107999003322226014","article-title":"Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus","volume":"23","author":"Wu","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0400","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1099\/0022-1317-81-11-2665","article-title":"The in vivo effects of recombinant bovine herpesvirus-1b expressing bovine interferon-gamma","volume":"81","author":"Ragoo","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0405","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1743-422X-8-7","article-title":"GM-CSF and IL-2 as adjuvant enhance the immune effect of protein vaccine against foot-and-mouth disease","volume":"8","author":"Zhang","year":"2011","journal-title":"Virol J"},{"issue":"40","key":"10.1016\/j.vaccine.2014.11.055_bib0410","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1016\/j.vaccine.2008.03.089","article-title":"The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination","volume":"26","author":"Su","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2014.11.055_bib0415","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.4049\/jimmunol.136.12.4561","article-title":"Cloning, sequence, and expression of bovine interferon-gamma","volume":"136","author":"Cerretti","year":"1986","journal-title":"J Immunol"},{"issue":"1\u20134","key":"10.1016\/j.vaccine.2014.11.055_bib0420","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-2427(87)90140-1","article-title":"Bovine interleukin 2: cloning, high level expression, and purification","volume":"17","author":"Baker","year":"1987","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0425","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/10425179209020821","article-title":"Nucleotide sequence of bovine interleukin-6 cDNA","volume":"2","author":"Droogmans","year":"1992","journal-title":"DNA Seq"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.055_bib0430","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.virol.2003.12.007","article-title":"Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX","volume":"320","author":"Zakhartchouk","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1001147","article-title":"Enhancing oral vaccine potency by targeting intestinal M cells","volume":"6","author":"Azizi","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0440","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00149-1","article-title":"Exploiting M cells for drug and vaccine delivery","volume":"50","author":"Clark","year":"2001","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0445","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1023\/B:PHAM.0000022418.80506.9a","article-title":"In-vivo phage display to identify M cell-targeting ligands","volume":"21","author":"Higgins","year":"2004","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.vaccine.2014.11.055_bib0450","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bbrc.2004.12.099","article-title":"Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture","volume":"327","author":"Bangari","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0455","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/211102a0","article-title":"Oncogenicity of bovine adenovirus-3 in hamsters","volume":"211","author":"Darbyshire","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0460","first-page":"61","volume":"27","author":"Zalmanzon","year":"1981","journal-title":"Vopr Onkol"},{"issue":"6","key":"10.1016\/j.vaccine.2014.11.055_bib0465","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","author":"Robert-Gurroff","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0470","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.vaccine.2006.03.048","article-title":"Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques","volume":"24","author":"Gomez-Roman","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0475","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomized, double blind, placebo-controlled, phase 1 study","volume":"13","author":"Gurwith","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2014.11.055_bib0480","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.cgt.7700765","article-title":"Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety and transmission","volume":"11","author":"Lichtenstein","year":"2004","journal-title":"Cancer Gene Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14016120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14016120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:05:59Z","timestamp":1747181159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14016120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0264410X14016120"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bovine adenovirus-3 as a vaccine delivery vehicle","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}